Results 141 to 150 of about 80,955 (266)
Effects of unilateral versus bilateral training on linear sprint and change-of-direction performance in athletes: a systematic review and meta-analysis. [PDF]
Dong C, Zhang Y, Sun M.
europepmc +1 more source
KDM7A and KDM1A inhibition suppresses tumour promoting pathways in prostate cancer
Treatment resistance is a major challenge for patients with advanced prostate cancer. This study examined an alternative approach to target the major prostate cancer‐promoting pathway by targeting epigenetic factors, whose levels are higher in tumours.
Jennie N Jeyapalan +16 more
wiley +1 more source
Optimization of an Ion-Bridge-Based Microbial Fuel Cell for Treatment of a Municipal Wastewater Sample. [PDF]
Ojha R, Pradhan D.
europepmc +1 more source
RNA profiling of circulating extracellular vesicles (EVs) from blood samples of men undergoing prostate biopsy identifies transcripts associated with clinically significant prostate cancer. Integrative analysis with public tumor datasets links EV‐derived gene signatures to tumor stage and progression‐free survival, highlighting CASP3, XRCC2, and RIT1 ...
Stefan Werner +14 more
wiley +1 more source
Physical Performance Differences Across Competitive Stages in Brazilian Women's Football: A Capacity-Specific Analysis from Under-14 to Professional Players. [PDF]
Preissler AAB +5 more
europepmc +1 more source
This study shows that lung adenocarcinomas exploit developmental branching morphogenesis to acquire a therapy resistant basal‐like tumour cell state. This process was found to be regulated by combined TP53 loss‐of‐function and type‐I interferon signalling, identifying a novel axis for biomarker and therapeutic target discovery.
Kamila J Bienkowska +13 more
wiley +1 more source
Movement Strategies During the Penultimate and Final Steps of a Change of Direction Following Arthroscopic Partial Meniscectomy. [PDF]
Starbuck C +4 more
europepmc +1 more source
Comparison of Oxidizing Abilities of COD Measurement Methods. COD(Cr) and COD(Mn) Methods.
Tetsutaro YOSHINAGA +2 more
openaire +2 more sources
Combining osimertinib with the STING agonist ADU‐S100 activates innate and adaptive immunity to overcome the non‐inflamed microenvironment of Egfr‐mutant lung cancer. This combination increases NK and CD8+ T‐cell infiltration, associated with activation of the STING‐IRF3 pathway and local immunogenic cell death.
Jun Nishimura +19 more
wiley +1 more source

